BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26369879)

  • 1. Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.
    Anglada-Huguet M; Vidal-Sancho L; Giralt A; García-Díaz Barriga G; Xifró X; Alberch J
    Neurobiol Dis; 2016 Nov; 95():22-34. PubMed ID: 26369879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
    Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
    Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington's disease.
    Anglada-Huguet M; Xifró X; Giralt A; Zamora-Moratalla A; Martín ED; Alberch J
    Mol Neurobiol; 2014 Apr; 49(2):784-95. PubMed ID: 24198227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
    Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E
    Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
    Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
    Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression.
    Giralt A; Rodrigo T; Martín ED; Gonzalez JR; Milà M; Ceña V; Dierssen M; Canals JM; Alberch J
    Neuroscience; 2009 Feb; 158(4):1234-50. PubMed ID: 19121372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
    Vidal-Sancho L; Fernández-García S; Solés-Tarrés I; Alberch J; Xifró X
    Mol Neurobiol; 2020 Nov; 57(11):4549-4562. PubMed ID: 32757160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.
    Saavedra A; Giralt A; Arumí H; Alberch J; Pérez-Navarro E
    PLoS One; 2013; 8(9):e73664. PubMed ID: 24040016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
    Murphy KP; Carter RJ; Lione LA; Mangiarini L; Mahal A; Bates GP; Dunnett SB; Morton AJ
    J Neurosci; 2000 Jul; 20(13):5115-23. PubMed ID: 10864968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.
    Dallérac GM; Cummings DM; Hirst MC; Milnerwood AJ; Murphy KP
    Neuromolecular Med; 2016 Mar; 18(1):146-53. PubMed ID: 26782175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.
    Murmu RP; Li W; Szepesi Z; Li JY
    J Neurosci; 2015 Jan; 35(1):287-98. PubMed ID: 25568121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice.
    Ransome MI; Hannan AJ
    Neurobiol Learn Mem; 2012 Feb; 97(2):261-70. PubMed ID: 22261461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice.
    Mo C; Pang TY; Ransome MI; Hill RA; Renoir T; Hannan AJ
    Neurobiol Dis; 2014 Sep; 69():248-62. PubMed ID: 24825316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington's disease models.
    Zhang H; Zhang C; Vincent J; Zala D; Benstaali C; Sainlos M; Grillo-Bosch D; Daburon S; Coussen F; Cho Y; David DJ; Saudou F; Humeau Y; Choquet D
    Nat Commun; 2018 Oct; 9(1):4272. PubMed ID: 30323233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's Disease.
    Bulley SJ; Drew CJ; Morton AJ
    J Huntingtons Dis; 2012; 1(2):267-73. PubMed ID: 25063335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.
    Giralt A; Saavedra A; Carretón O; Arumí H; Tyebji S; Alberch J; Pérez-Navarro E
    Hippocampus; 2013 Aug; 23(8):684-95. PubMed ID: 23576401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.
    Ciamei A; Morton AJ
    Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice.
    Espina M; Di Franco N; Brañas-Navarro M; Navarro IR; Brito V; Lopez-Molina L; Costas-Insua C; Guzmán M; Ginés S
    Neurobiol Dis; 2023 Aug; 184():106225. PubMed ID: 37442396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
    Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
    Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.